Rejoinder

International Journal of Epidemiology

Volumn 33, Issue 1, 2004, Pages 69-73

  Freedman, David A ^a   Petitti, Diana B ^a   Robins, James M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CANCER; BREAST EXAMINATION; CALCULATION; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; METHODOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 12344290910     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyh061     Document Type: Article

References (37)

1. Freedman DA, Petitti DB, Robins JM. On the efficacy of screening for breast cancer. Int J Epidemiol 2004;33:43-55.
2. Gøtzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34. Discussion, Lancet 2000;355:747-52.
3. Olsen O, Gøtzsche PC. Screening for Breast Cancer with Mammography (Cochrane Review). Oxford: Update Software. The Cochrane Library, Issue 4, 2001.
4. Olsen O, Gøtzsche PC. Systematic Screening for Breast Cancer with Mammography. 2001. http://image.thelancet.com/lancet/extra/fullreport.pdf
5. Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-42. Discussion, Lancet 2001;358:2164-68.
6. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: Updated overview of the Swedish randomised trials Lancet 2002;359:909-19. Discussion, 2002;360:337-40.
7. Health Council of the Netherlands. The Benefit of Population Screening for Breast Cancer with Mammography. The Hague, 2002.
8. US Preventive Services Task Force. Screening for breast cancer: Recommendations and rationale. Ann Intern Med 2002;137:344-46.
9. US Preventive Services Task Force. Breast cancer screening: A summary of the evidence. Ann Intern Med 2002;137:347-67.
10. International Agency for Research on Cancer. Breast Cancer Screening. Lyon: IARC. IARC Handbooks of Cancer Prevention, Vol. 7, 2002.
11. Gøtzsche P. On the benefits and harms of screening for breast cancer. Int J Epidemiol 2004;33:56-64.
12. Gøtzsche P. Screening for colorectal cancer. Letter. Lancet 1997; 349:356.
13. US Census Bureau. Statistical Abstract of the United States. Washington, DC, 2000.
14. Tarone RE, Chu KC. Implications of birth cohort patterns in interpreting trends in breast cancer rates. J Natl Cancer Inst 1992;84:1402-10.
15. Liff JM, Sung JF, Chow WH, Greenberg RS, Flanders WD. Does increased detection account for the rising incidence of breast cancer? Am J Public Health 1991;81:462-65.
16. Ries LAG, Eisner MP, Kosary CL et al. (eds). SEER Cancer Statistics Review, 1973-1999. Bethesda, MD.: National Cancer Institute, 2002. http://seer.cancer.gov/csr/1973_1999/.
17. Miller AB. Screening for breast cancer with mammography. Letter. Lancet 2001;358:2164.
18. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Selection, follow-up, and analysis in the Health Insurance Plan study: A randomized trial with breast cancer screening. In: Garfinkel L,Ochs O,Mushinski M (eds). Selection, Follow-up, and Analysis in Prospective Studies: a Workshop. National Cancer Institute Monograph 67. Bethesda, MD: National Cancer Institute, May 1985, pp. 65-74. Discussion, pp. 75-79. (NIH publication no. 85-2713.)
19. Shapiro S, Venet W, Strax P, Venet L. Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1963-1986. Baltimore: Johns Hopkins, 1988.
20. Gotzsche PC. Screening for breast cancer with mammography. Author's reply. Lancet 2001;358:2167-68.
21. Nyström L, Larsson LG. Breast cancer screening with mammography. Letter. Lancet 1993;341:1531-32.
22. Tabár L, Fagerberg G, Chen HH et al. Efficacy of breast cancer screening by age: New results from the Swedish two-county trial. Cancer 1995;75:2507-17.
23. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992;147:1459-76.
24. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: Breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002;137:305-12.
25. Mettlin CJ, Smart CR. The Canadian National Breast Screening Study: An appraisal and implications for early detection policy. Cancer 1993;72(Suppl.):1461-65.
26. Tarone RE. The excess of patients with advanced breast cancers in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 1995;75: 997-1003.
27. Miller AB. Commentary: A defence of the Health Insurance Plan (HIP) study and the Canadian National Breast Screening Study (CNBSS). Int J Epidemiol 2004;33:64-65.
28. Berry DA. Screening mammography: a decision analysis. Int J Epidemiol 2004;33:68.
29. Berry DA. Benefits and risks of screening mammography for women in their forties: A statistical appraisal. J Natl Cancer Inst 1998;90:1431-39.
30. Kolata G. Different conclusions from the same study. New York Times, 9 April 2002, p. D4.
31. Baum M. Commentary: False premises, false promises and false positives - the case against mammographic screening for breast cancer. Int J Epidemiol 2004;33:66-67.
32. Nyström L, Larsson LG, Wall S et al. An overview of the Swedish randomized mammography trials: Total mortality pattern and the representivity of the study cohorts. J Med Screening 1996;3: 85-87.
33. Duffy SW. Interpretation of the breast screening trials: A commentary on the recent paper by Gøtzsche and Olsen. The Breast 2001; 10:209-12.
34. Hearst N, Newman TB, Hulley SB. Delayed effects of the military draft on mortality: a randomized natural experiment. New Engl J Med 1986;314:620-24.
35. Sommer A, Zeger SL. On estimating efficacy from clinical trials. Stat Med 1991;10:45-52.
36. Angrist J, Imbens G. Identification and estimation of local average treatment effects. Econometrica 1994;62:467-75.
37. Chu KC, Smart CR, Tarone RE. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst 1988;80:1125-32.